Task: Answer the multiple choice question.
Question: Which drug exhibits a 2.165\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a. CC(=O)Nc1ccc(NC(=O)C(C)OC(=O)c2ccccc2C(=O)c2ccc(Cl)c([N+](=O)[O-])c2)cc1
b. CC(=O)N1CCN(S(=O)(=O)c2cccc(C(=O)OCC(=O)N(CCC#N)c3ccc(F)cc3)c2)CC1
c. Cn1c2ccccc2c(=O)c2c(=O)n(Cc3ccccc3)c(-c3ccc(F)cc3)nc21
d. CCN(CC)C(=O)C1CCCN(Cc2ccc(OC)c(C)c2)C1
e. Cc1ccc(-n2ncc3c2CCCC3NC(=O)CCc2cnccn2)cc1C
Answer: e. Cc1ccc(-n2ncc3c2CCCC3NC(=O)CCc2cnccn2)cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-n2ncc3c2CCCC3NC(=O)CCc2cnccn2)cc1C
Cc1ccc(-n2ncc3c2CCCC3NC(=O)CCc2cnccn2)cc1C
N-[1-(3,4-dimethylphenyl)-4,5,6,7-tetrahydroindazol-4-yl]-3-pyrazin-2-ylpropanamide